Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Heme Oxygenase-1 in Central Nervous System Malignancies
Giuseppe Sferrazzo, Michelino Di Rosa, Eugenio Barone, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 5, pp. 1562-1562
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Heme Oxygenase-1 Signaling and Redox Homeostasis in Physiopathological Conditions
Valeria Consoli, Valeria Sorrenti, Salvo Grosso, et al.
Biomolecules (2021) Vol. 11, Iss. 4, pp. 589-589
Open Access | Times Cited: 176
Heme Oxygenase-1: An Anti-Inflammatory Effector in Cardiovascular, Lung, and Related Metabolic Disorders
Stefan W. Ryter
Antioxidants (2022) Vol. 11, Iss. 3, pp. 555-555
Open Access | Times Cited: 147
Control of Oxidative Stress in Cancer Chemoresistance: Spotlight on Nrf2 Role
Giuseppina Barrera, Marie Angèle Cucci, Margherita Grattarola, et al.
Antioxidants (2021) Vol. 10, Iss. 4, pp. 510-510
Open Access | Times Cited: 63
The Interplay between Glioblastoma Cells and Tumor Microenvironment: New Perspectives for Early Diagnosis and Targeted Cancer Therapy
Assunta Virtuoso, Giuseppa D’Amico, Federica Scalia, et al.
Brain Sciences (2024) Vol. 14, Iss. 4, pp. 331-331
Open Access | Times Cited: 9
Therapeutic Potential of Heme Oxygenase-1 and Carbon Monoxide in Acute Organ Injury, Critical Illness, and Inflammatory Disorders
Stefan W. Ryter
Antioxidants (2020) Vol. 9, Iss. 11, pp. 1153-1153
Open Access | Times Cited: 58
Metabolic Drivers of Invasion in Glioblastoma
Joseph H. Garcia, Saket Jain, Manish K. Aghi
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 51
Clinical Significance of Heme Oxygenase 1 in Tumor Progression
Mariapaola Nitti, Caterina Ivaldo, Nicola Traverso, et al.
Antioxidants (2021) Vol. 10, Iss. 5, pp. 789-789
Open Access | Times Cited: 46
Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms
Filippo Torrisi, Simona D’Aprile, Simona Denaro, et al.
Antioxidants (2023) Vol. 12, Iss. 2, pp. 220-220
Open Access | Times Cited: 16
Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implications
İlhan Yaylım, Melek Aru, Ammad Ahmad Farooqı, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 6
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent In Vitro Antiproliferative Activity
Antonino N. Fallica, Valeria Sorrenti, Agata Grazia D’Amico, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13373-13393
Open Access | Times Cited: 29
A pathogenic subpopulation of human glioma associated macrophages linked to glioma progression
Kenny Yu, Zaki Abou-Mrad, Kristof A. Torkenczy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia
Marzia Perluigi, Antonella Tramutola, Sara Pagnotta, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 779-779
Open Access | Times Cited: 32
Carbon monoxide (CO)/heme oxygenase (HO)-1 in gastrointestinal tumors pathophysiology and pharmacology - possible anti- and pro-cancer activities
Kinga Krukowska, Marcin Magierowski
Biochemical Pharmacology (2022) Vol. 201, pp. 115058-115058
Open Access | Times Cited: 17
The dual role and mutual dependence of heme/HO-1/Bach1 axis in the carcinogenic and anti-carcinogenic intersection
Jinjing Xu, Kuiyang Zhu, Yali Wang, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 1, pp. 483-501
Closed Access | Times Cited: 16
Microfluidic-derived docosahexaenoic acid liposomes for glioblastoma therapy
Daniel Mendanha, Sara Gimondi, Bruno M. Costa, et al.
Nanomedicine Nanotechnology Biology and Medicine (2023) Vol. 53, pp. 102704-102704
Open Access | Times Cited: 9
Novel Acetamide-Based HO-1 Inhibitor Counteracts Glioblastoma Progression by Interfering with the Hypoxic–Angiogenic Pathway
Agata Grazia D’Amico, Grazia Maugeri, Luca Vanella, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5389-5389
Open Access | Times Cited: 3
The Role of Bilirubin and the Other “Yellow Players” in Neurodegenerative Diseases
Sri Jayanti, Libor Vı́tek, Claudio Tiribelli, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 900-900
Open Access | Times Cited: 27
Heme oxygenase 1: a novel oncogene in multiple gynecological cancers
Jia-Jing Lu, Ayitila Abudukeyoumu, Xing Zhang, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 9, pp. 2252-2261
Open Access | Times Cited: 23
Role of Nrf2 and HO-1 in intervertebral disc degeneration
Cangyu Zhang, Xuchang Hu, Guangzhi Zhang, et al.
Connective Tissue Research (2022) Vol. 63, Iss. 6, pp. 559-576
Closed Access | Times Cited: 10
An Analysis of the Multifaceted Roles of Heme in the Pathogenesis of Cancer and Related Diseases
Tianyuan Wang, Adnin Ashrafi, Pouya Modareszadeh, et al.
Cancers (2021) Vol. 13, Iss. 16, pp. 4142-4142
Open Access | Times Cited: 14
Protective effects of silymarin in glioblastoma cancer cells through redox system regulation
Sara Zarei Shandiz, Bahareh Erfani, Seyed Isaac Hashemy
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 1
The Neural Palette of Heme: Altered Heme Homeostasis Underlies Defective Neurotransmission, Increased Oxidative Stress, and Disease Pathogenesis
Adedamola Saidi Soladogun, Zhang Li
Antioxidants (2024) Vol. 13, Iss. 12, pp. 1441-1441
Open Access | Times Cited: 1
Multiple Antitumor Molecular Mechanisms Are Activated by a Fully Synthetic and Stabilized Pharmaceutical Product Delivering the Active Compound Sulforaphane (SFX-01) in Preclinical Model of Human Glioblastoma
Alessandro Colapietro, Alessandra Rossetti, A. Mancini, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1082-1082
Open Access | Times Cited: 9
miR-127-5p Targets JAM3 to Regulate Ferroptosis, Proliferation, and Metastasis in Malignant Meningioma Cells
Jing Zhang, Zang Liu, Yipeng Dong
Disease Markers (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 6
Transcriptomics-Based Phenotypic Screening Supports Drug Discovery in Human Glioblastoma Cells
В. А. Шаповалов, Liliya Kopanitsa, Lavinia-Lorena Pruteanu, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3780-3780
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top